Tag: Orthos

Ortho’s VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries

RARITAN, N.J., April 16, 2019 /PRNewswire/ — Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced CE Mark for its next-generation VITROS® High Sensitivity Troponin I assay. This new assay is the latest addition to the company’s robust cardiology menu and is a critical tool for clinicians who are seeking improved […]